CY3 100tab – Dragon Pharma

$54.00

Availability: Out of Stock

FAT BURNING STACK 6.02 MG TABS
Drug Class: Beta-2 Agonist, Thyroid Hormone
Composition:
– Active Substances: Clenbuterol (37 mcg), Liothyronine Sodium (25 mcg), Yohimbine (5.4 mg)
– Concentration: 6.02 mg/tab
Presentation: 100 tabs
Manufacturer: Dragon Pharma

Out of stock

SKU: RF-Dragon Pharma-int4281 Categories: , ,

Reviews

There are no reviews yet.

Be the first to review “CY3 100tab – Dragon Pharma”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsCY3 100tab - Dragon Pharma removeHalomed 5mg – Fluoxymesterone – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention removeLetrozone - Letrozole 5mg/100 tabs. removeWinimed 10mg – Stanozolol – Deus Medical removeStanzone - Stanozolol 10mg. remove
Image
Int'l
EU
EU
USA
EU
EU
SKURF-Dragon Pharma-int4281101AAS-DM-0-116101AAS-HB-0-139RF-AlphaZone-upline5233101AAS-DM-0-101RF-AlphaZone-upline7147
Rating
Price$54.00 $99.00 $75.00$95.99 $48.00$89.99
Stock

Out of stock

Out of stock

Out of stock

AvailabilityOut of stockOut of stockOut of stock
Add to cart

Read more

Add to cart

Add to cart

Read more

Add to cart

Read more

DescriptionFAT BURNING STACK 6.02 MG TABS Drug Class: Beta-2 Agonist, Thyroid Hormone Composition: - Active Substances: Clenbuterol (37 mcg), Liothyronine Sodium (25 mcg), Yohimbine (5.4 mg) - Concentration: 6.02 mg/tab Presentation: 100 tabs Manufacturer: Dragon PharmaSubstance: Fluoxymesterone Application: Oral Dosage: 5 mg/tab Packing: 50 Tablets per Box Elimination half-life: 9.2 hours Drug Class: Androgen, Anabolic steroid.CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: EuropeACTIVE INGREDIENT: LETROZOLE 5mg TABLET COUNT: 100 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANTI ESTROGEN DOSAGE: 5mg ACNE: NONE WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NOActive Ingredient: Stanozolol 10mg Tablet Count: 50 Tablets Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 20-50 Mg/day Acne: Yes Water Retention: No Hbr: Perhaps Hepatoxity: YesActive Ingredient: Stanozolol 10mg Tablet Count: 100 tabs Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 20-50 Mg/day Acne: Yes Water Retention: No Hbr: perhaps Hepatoxicity: yes Aromatization: No Ship From: USA
ContentLetrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature.Letrozole 5mg x 100 tablets Letrozole is a third generation Aromatase Inhibitor (AI) that works by attaching to -and eliminating the aromatase enzyme resposible for producing estrogen. This makes it a perfect choice to combat gynocomastia which it will completely prevent. Letrozole also quite raises LH levels which deems it suitable for post-cycle use. The human body does need estrogen to maintain proper immune function and balance cholesterol ratios in the blood. Since letrozole is so strong at eliminating estrogen, it is not suited for long term use.Stanozolol 10mg x 100 tablets Stanzolol is a derivative of dihydrotestosterone, although its activity is much milder than this androgen in nature. It is technically classified as an anabolic steroid, shown to exhibit a slightly greater tendency for muscle growth than androgenic activity in early studies.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information